Providing capital and market access to build industry leaders

About ArchiMed

ArchiMed is a leading private equity firm focused exclusively on the healthcare industry. ArchiMed serves as a strategic and financial partner to European and North American small and middle-market businesses in targeted segments of healthcare including; pharmaceuticals, medical devices & technology, healthcare IT and consumer health. ArchiMed’s strategy is based upon healthcare specialization, integrated private equity, medical and operating expertise, and its unique trans-Atlantic platform that supports growth through internationalization.

Over the last 20 years, ArchiMed’s leadership team has directly managed and invested in over 40 small to large-sized healthcare companies globally, representing over €5 billion of total invested capital.

ArchiMed currently manages nearly €2 billion in assets across four funds, small-cap focused MED I and MED II, gene & cell therapy focused PolyMED, and mid-cap focused MED Platform I. ArchiMed is also an Impact Investor and a signatory of the Principles for Responsible Investment pledged to uphold the United Nations’ Sustainable Development Goals.

Facts & Figures

As of June 2021

  • Dedicated to the healthcare industries
  • Ability to invest globally with European focus
  • Headquarters in Lyon with European and North American coverage
  • International culture at team and individual levels
  • Medical, scientific, operational and financial backgrounds
  • Long term relations with entrepreneurs
  • Several investment vehicles providing flexibility on investment size
  • Eurêka Foundation dedicated to the recovery of fragile people
  • Founded in 2014 on the basis of 30 years track-record
  • 50+ team members, of which half healthcare industry insiders
  • 20+ nationalities in ArchiMed team
  • Directly invested in 7 European countries and in the US
  • Investment size from EUR 5M to 500M
  • >50 investments and >€5bn invested at team level
  • 18+ portfolio companies as of June 2021
  • >100 patients supported through Eurêka Foundation